112 related articles for article (PubMed ID: 28895642)
1. Initiation of Basal Insulin Analog Treatment for Type 2 Diabetes and Reasons Behind Patients' Treatment Persistence Behavior: Real-World Data from Germany.
Moennig E; Perez-Nieves M; Hadjiyianni I; Cao D; Ivanova J; Klask R
Exp Clin Endocrinol Diabetes; 2018 May; 126(5):287-297. PubMed ID: 28895642
[TBL] [Abstract][Full Text] [Related]
2. Basal insulin initiation use and experience among people with type 2 diabetes mellitus with different patterns of persistence: results from a multi-national survey.
Perez-Nieves M; Ivanova JI; Hadjiyianni I; Zhao C; Cao D; Schmerold L; Kalirai S; King S; DeLozier AM; Birnbaum HG; Peyrot M
Curr Med Res Opin; 2017 Oct; 33(10):1833-1842. PubMed ID: 28604111
[TBL] [Abstract][Full Text] [Related]
3. Associated factors that influenced persistence with basal analog insulin therapy among people with type 2 diabetes: An exploratory analysis from a UK real-world sample.
Idris I; Gulati K; Perez-Nieves M; Hadjiyianni I; Cao D; Tahbaz A; Ivanova J; Hassan SW
Prim Care Diabetes; 2019 Apr; 13(2):106-112. PubMed ID: 30477969
[TBL] [Abstract][Full Text] [Related]
4. Basal insulin persistence, associated factors, and outcomes after treatment initiation among people with type 2 diabetes mellitus in the US.
Perez-Nieves M; Kabul S; Desai U; Ivanova JI; Kirson NY; Cummings AK; Birnbaum HG; Duan R; Cao D; Hadjiyianni I
Curr Med Res Opin; 2016; 32(4):669-80. PubMed ID: 26703951
[TBL] [Abstract][Full Text] [Related]
5. Basal insulin persistence in Brazilian participants with T2DM.
Franco DR; Perez-Nieves M; Ivanova JI; Cao D; Vaz MSC
Rev Assoc Med Bras (1992); 2019; 65(10):1254-1264. PubMed ID: 31721957
[TBL] [Abstract][Full Text] [Related]
6. Correlates of basal insulin persistence among insulin-naïve people with type 2 diabetes: results from a multinational survey.
Peyrot M; Perez-Nieves M; Ivanova J; Cao D; Schmerold L; Kalirai S; Hadjiyianni I
Curr Med Res Opin; 2017 Oct; 33(10):1843-1851. PubMed ID: 28604112
[TBL] [Abstract][Full Text] [Related]
7. Basal Insulin Persistence, Associated Factors, and Outcomes After Treatment Initiation: A Retrospective Database Study Among People with Type 2 Diabetes Mellitus in Japan.
Hadjiyianni I; Desai U; Suzuki S; Ivanova JI; Cao D; Kirson NY; Chida D; Enloe C; Birnbaum HG; Perez-Nieves M
Diabetes Ther; 2017 Feb; 8(1):149-166. PubMed ID: 27913984
[TBL] [Abstract][Full Text] [Related]
8. Basal Insulin Initiation and Maintenance in Adults with Type 2 Diabetes Mellitus in the United States.
Kalirai S; Ivanova JI; Perez-Nieves M; Stephenson JJ; Hadjiyianni I; Grabner M; Pollom RD; Geremakis C; Reed BL; Fisher L
Diabetes Metab Syndr Obes; 2020; 13():1023-1033. PubMed ID: 32308452
[TBL] [Abstract][Full Text] [Related]
9. Treatment persistence in the use of basal insulins in Poland and Germany
.
Rathmann W; Czech M; Franek E; Kostev K
Int J Clin Pharmacol Ther; 2017 Feb; 55(2):119-125. PubMed ID: 27879196
[TBL] [Abstract][Full Text] [Related]
10. Impact of initiating insulin glargine disposable pen versus vial/syringe on real-world glycemic outcomes and persistence among patients with type 2 diabetes mellitus in a large managed care plan: a claims database analysis.
Xie L; Zhou S; Pinsky BW; Buysman EK; Baser O
Diabetes Technol Ther; 2014 Sep; 16(9):567-75. PubMed ID: 24735083
[TBL] [Abstract][Full Text] [Related]
11. Treatment persistence after initiating basal insulin in type 2 diabetes patients: A primary care database analysis.
Pscherer S; Chou E; Dippel FW; Rathmann W; Kostev K
Prim Care Diabetes; 2015 Oct; 9(5):377-84. PubMed ID: 25701545
[TBL] [Abstract][Full Text] [Related]
12. Adherence and persistence to a regimen of basal insulin in a pre-filled pen compared to vial/syringe in insulin-naïve patients with type 2 diabetes.
Buysman E; Conner C; Aagren M; Bouchard J; Liu F
Curr Med Res Opin; 2011 Sep; 27(9):1709-17. PubMed ID: 21740289
[TBL] [Abstract][Full Text] [Related]
13. Does pen help? A real-world outcomes study of switching from vial to disposable pen among insulin glargine-treated patients with type 2 diabetes mellitus.
Xie L; Zhou S; Wei W; Gill J; Pan C; Baser O
Diabetes Technol Ther; 2013 Mar; 15(3):230-6. PubMed ID: 23336845
[TBL] [Abstract][Full Text] [Related]
14. Incidence, worry and discussion about dosing irregularities and self-treated hypoglycaemia amongst HCPs and patients with type 2 diabetes: results from the UK cohort of the Global Attitudes of Patient and Physicians (GAPP2) survey.
Munro N; Barnett AH
Int J Clin Pract; 2014 Jun; 68(6):692-9. PubMed ID: 24548693
[TBL] [Abstract][Full Text] [Related]
15. Insulin non-persistence among people with type 2 diabetes: how to get your patients to stay on insulin therapy.
Garnero TL; Davis NJ; Perez-Nieves M; Hadjiyianni I; Cao D; Ivanova JI; Peyrot M
Postgrad Med; 2018 May; 130(4):394-401. PubMed ID: 29571275
[TBL] [Abstract][Full Text] [Related]
16. Real-world comparative outcomes of US type 2 diabetes patients initiating analog basal insulin therapy.
Davis KL; Tangirala M; Meyers JL; Wei W
Curr Med Res Opin; 2013 Sep; 29(9):1083-91. PubMed ID: 23734906
[TBL] [Abstract][Full Text] [Related]
17. Dosing irregularities and self-treated hypoglycemia in type 2 diabetes: results from the Canadian cohort of an international survey of patients and healthcare professionals.
Leiter LA; Boras D; Woo VC
Can J Diabetes; 2014 Feb; 38(1):38-44. PubMed ID: 24485212
[TBL] [Abstract][Full Text] [Related]
18. A cross-sectional survey among patients and prescribers on insulin dosing irregularities and impact of mild (self-treated) hypoglycemia episodes in Spanish patients with type 2 diabetes as compared to other European patients.
Ampudia-Blasco FJ; Galán M; Brod M
Endocrinol Nutr; 2014 Oct; 61(8):426-33. PubMed ID: 24853553
[TBL] [Abstract][Full Text] [Related]
19. [Adherence of type 2 diabetes patients on insulin analogues application: missed dose, time imprecision and dose reduction. The results of GAPP2TM(Global Attitudes of Physicians and Patient) survey in the Czech Republic].
Prázný M
Vnitr Lek; 2014 Nov; 60(11):999-1006. PubMed ID: 25600048
[TBL] [Abstract][Full Text] [Related]
20. Understanding suboptimal insulin use in type 1 and 2 diabetes: a cross-sectional survey of healthcare providers who treat people with diabetes.
Newson RS; Spaepen E; Liao B; Bower J; Bhattacharya I; Artime E; Polonsky W
BMC Prim Care; 2024 Apr; 25(1):124. PubMed ID: 38649812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
